KANEKO YASUNORI 4
4 · Arcus Biosciences, Inc. · Filed Jun 7, 2021
Insider Transaction Report
Form 4
KANEKO YASUNORI
Director
Transactions
- Award
Common Stock
2021-06-03+3,000→ 6,000 total - Award
Stock Option (Right to Buy)
2021-06-03+14,100→ 14,100 totalExercise: $24.79Exp: 2031-06-02→ Common Stock (14,100 underlying)
Holdings
- 136,081(indirect: By Trust)
Common Stock
- 505,050(indirect: By LLC)
Common Stock
- 252,524(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Represents the grant of restricted stock units that vest 100% on the earlier of June 3, 2022 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2021.
- [F3]Four thousand one hundred thirty-three (4,133) shares previously held directly by the reporting person were transferred to reporting person's trust.
- [F4]The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.